Automatic classification of AD pathology in FTD phenotypes using natural speech
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Sunghye Cho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Linguistic Data Consortium, Department of Linguistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Frontotemporal Dementia, Magnetic Resonance Imaging, Speech. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Alzheimer's Association.
Abstract (Originalsprache)
INTRODUCTION Screening for Alzheimer's disease neuropathologic change (ADNC) in individuals with atypical presentations is challenging but essential for clinical management. We trained automatic speech‐based classifiers to distinguish frontotemporal dementia (FTD) patients with ADNC from those with frontotemporal lobar degeneration (FTLD). METHODS We trained automatic classifiers with 99 speech features from 1 minute speech samples of 179 participants (ADNC = 36, FTLD = 60, healthy controls [HC] = 89). Patients’ pathology was assigned based on autopsy or cerebrospinal fluid analytes. Structural network‐based magnetic resonance imaging analyses identified anatomical correlates of distinct speech features. RESULTS Our classifier showed 0.88 0.03 area under the curve (AUC) for ADNC versus FTLD and 0.93 0.04 AUC for patients versus HC. Noun frequency and pause rate correlated with gray matter volume loss in the limbic and salience networks, respectively. DISCUSSION Brief naturalistic speech samples can be used for screening FTD patients for underlying ADNC in vivo. This work supports the future development of digital assessment tools for FTD. Highlights We trained machine learning classifiers for frontotemporal dementia patients using natural speech. We grouped participants by neuropathological diagnosis (autopsy) or cerebrospinal fluid biomarkers. Classifiers well distinguished underlying pathology (Alzheimer's disease vs. frontotemporal lobar degeneration) in patients. We identified important features through an explainable artificial intelligence approach. This work lays the groundwork for a speech‐based neuropathology screening tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Linguistic Data Consortium, Department of Linguistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Sunghye Cho
Förderung
- NIA NIH HHS
- NIH HHS
- Alzheimer's Association
- Department of Defense
- National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Cho, S., Olm, C. A., Ash, S., Shellikeri, S., Agmon, G., Cousins, K. A. Q., Irwin, D. J., Grossman, M., Liberman, M., & Nevler, N. (2024). Automatic classification of AD pathology in FTD phenotypes using natural speech. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13748
Vancouver
Cho S, Olm CA, Ash S, Shellikeri S, Agmon G, Cousins KAQ, et al. Automatic classification of AD pathology in FTD phenotypes using natural speech. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13748
BibTeX
@article{Cho2024,
author = {Cho, Sunghye and Olm, Christopher A and Ash, Sharon and Shellikeri, Sanjana and Agmon, Galit and Cousins, Katheryn A Q and Irwin, David J and Grossman, Murray and Liberman, Mark and Nevler, Naomi},
title = {Automatic classification of AD pathology in FTD phenotypes using natural speech},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13748}
}
EUVIMED